Orphan Drug Exclusivity Keeps Biosimilars Off the Market ...
文章推薦指數： 80 %
Orphan Drug Exclusivity Keeps Biosimilars Off the Market, Study Says ... Investigators found that manufacturers appear to be exploiting orphan ... BusinessPracticeSeeAll>BusinessDevelopmentLegalPolicyPracticeRegulatoryAboutContactAdvisoryBoardDoNotSellMyInformationTerms&
延伸文章資訊
- 1Orphan Drugs in the United States - IQVIA
- 2Marketing Exclusivity for Drug Developers: What is it ...
Orphan drug exclusivity (ODE; 21 CFR 316.31) is used as an incentive to promote the development o...
- 3Orphan Drug Exclusivity Keeps Biosimilars Off the Market ...
Orphan Drug Exclusivity Keeps Biosimilars Off the Market, Study Says ... Investigators found that...
- 4Orphan drug - Wikipedia
An orphan drug is a pharmaceutical agent developed to treat medical conditions which, because the...
- 5The Enduring Role of Orphan Drug Exclusivity for Biologics ...
Orphan Drugs receive a 7-year period of exclusivity from product approval - effective on the date...
